Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SAFINAMIDE MESYLATE (PROCESS-2), with a corresponding US DMF Number 34628.
Remarkably, this DMF maintains an Active status since its submission on February 27, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 15, 2020, and payment made on August 12, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II